Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01972516
Title Tivozanib As Maintenance Therapy In GYN
Recruitment Terminated
Gender female
Phase Phase II
Variant Requirements No
Sponsors Dana-Farber Cancer Institute
Indications

fallopian tube cancer

ovarian cancer

peritoneum cancer

Therapies

Tivozanib

Age Groups: adult
Covered Countries USA


No variant requirements are available.